Thurston Springer Miller Herd & Titak’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150K Buy
629
+10
+2% +$2.08K 0.05% 291
2026
Q1
$131K Sell
619
-61
-9% -$13.1K 0.05% 325
2025
Q4
$140K Buy
+680
New +$128K 0.05% 300
2025
Q3
Sell
-1,074
Closed -$181K 654
2025
Q2
$181K Buy
1,074
+79
+8% +$11.7K 0.02% 382
2025
Q1
$137K Buy
995
+174
+21% +$22.2K 0.02% 402
2024
Q4
$97.3K Buy
821
+146
+22% +$17K 0.02% 394
2024
Q3
$74.7K Buy
675
+214
+46% +$22.4K 0.02% 462
2024
Q2
$45.4K Buy
+461
New +$47K 0.01% 576

Other funds holding CAH

Thurston Springer Miller Herd & Titak's CAH Position: Q2 2026 in Review

Thurston Springer Miller Herd & Titak increased its Cardinal Health (CAH) stake by 1.6% in Q2 2026, buying an estimated $2.08K and bringing the position to 629 shares worth $150K. The position accounts for 0.05% of the portfolio, ranked #291.

Thurston Springer Miller Herd & Titak first reported a position in CAH in Q2 2024 and has held it in 8 quarters since. The position peaked at $181K in Q2 2025. 499 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Thurston Springer Miller Herd & Titak held 629 shares of Cardinal Health worth $150K as of Q2 2026.
  • Thurston Springer Miller Herd & Titak bought 10 Cardinal Health shares in Q2 2026, an estimated $2.08K.
  • Cardinal Health made up 0.05% of Thurston Springer Miller Herd & Titak's portfolio in Q2 2026, its #291 holding.
  • Thurston Springer Miller Herd & Titak first reported a position in Cardinal Health in Q2 2024 and has held it in 8 quarters since.
  • Thurston Springer Miller Herd & Titak's Cardinal Health position peaked at $181K in Q2 2025.
  • 499 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Thurston Springer Miller Herd & Titak's 13F filing for Q2 2026, filed 8 Jul 2026.